These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 8563540)

  • 61. [Autoimmune phenomena following minocycline treatment].
    Elkayam O; Yaron M; Caspi D
    Harefuah; 1999 Mar; 136(5):400-3. PubMed ID: 10914249
    [No Abstract]   [Full Text] [Related]  

  • 62. Severe complication of a commonly prescribed drug: minocycline-induced lupus.
    Shepherd J
    J Am Board Fam Pract; 2002; 15(3):239-41. PubMed ID: 12038732
    [No Abstract]   [Full Text] [Related]  

  • 63. Complications of minocycline therapy for acne vulgaris: case reports and review of the literature.
    Somech R; Arav-Boger R; Assia A; Spirer Z; Jurgenson U
    Pediatr Dermatol; 1999; 16(6):469-72. PubMed ID: 10632948
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benefit-risk assessment of acne therapies.
    Bénéton N; Bocquet H; Cosnes A; Revuz J; Roujeau JC
    Lancet; 1997 Apr; 349(9060):1252. PubMed ID: 9130968
    [No Abstract]   [Full Text] [Related]  

  • 65. Minocycline-induced hepatitis.
    Nietsch HH; Libman BS; Pansze TW; Eicher JN; Reeves JR; Krawitt EL
    Am J Gastroenterol; 2000 Oct; 95(10):2993-5. PubMed ID: 11051393
    [No Abstract]   [Full Text] [Related]  

  • 66. Minocycline related lupus.
    Emery P; Gough A; Griffiths B
    J Rheumatol; 1997 Sep; 24(9):1850; author reply 1851-2. PubMed ID: 9292819
    [No Abstract]   [Full Text] [Related]  

  • 67. Minocycline-induced autoimmune hepatitis with subsequent cirrhosis.
    Chamberlain MC; Schwarzenberg SJ; Akin EU; Kurth MH
    J Pediatr Gastroenterol Nutr; 2006 Feb; 42(2):232-5. PubMed ID: 16456421
    [No Abstract]   [Full Text] [Related]  

  • 68. Perinuclear antineutrophilic cytoplasmic antibody-positive cutaneous polyarteritis nodosa associated with minocycline therapy for acne vulgaris.
    Schaffer JV; Davidson DM; McNiff JM; Bolognia JL
    J Am Acad Dermatol; 2001 Feb; 44(2):198-206. PubMed ID: 11174376
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Minocycline Topical Foam: A New Drug for the Treatment of Acne.
    Onge ES; Mobley WC
    Ann Pharmacother; 2021 Jan; 55(1):105-110. PubMed ID: 32618475
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Minocycline for acne vulgaris: efficacy and safety.
    Garner SE; Eady EA; Popescu C; Newton J; Li Wan Po A
    Cochrane Database Syst Rev; 2000; (2):CD002086. PubMed ID: 10796856
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Minocycline-induced arthritis.
    Knights SE; Leandro MJ; Khamashta MA; Hughes GR
    Clin Exp Rheumatol; 1998; 16(5):587-90. PubMed ID: 9779309
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Minocycline and lupuslike syndrome in acne patients.
    Sturkenboom MC; Meier CR; Jick H; Stricker BH
    Arch Intern Med; 1999 Mar; 159(5):493-7. PubMed ID: 10074958
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Minocycline-induced lupus-like syndrome.
    Balestrero S; Ciambellotti A; Parodi A; Rebora A
    Int J Dermatol; 2001 Jul; 40(7):474-5. PubMed ID: 11679009
    [No Abstract]   [Full Text] [Related]  

  • 74. Minocycline-induced pericardial effusion.
    Christe C; Ricou F; Stoller R; Vogt N
    Ann Pharmacother; 2000; 34(7-8):875-7. PubMed ID: 10928400
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Minocycline-induced clinical and biological lupus-like disease.
    Tournigand C; Généreau T; Prudent M; Diemert MC; Herson S; Chosidow O
    Lupus; 1999; 8(9):773-4. PubMed ID: 10602453
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative safety of tetracycline, minocycline, and doxycycline.
    Shapiro LE; Knowles SR; Shear NH
    Arch Dermatol; 1997 Oct; 133(10):1224-30. PubMed ID: 9382560
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Why minocycline can cause systemic lupus - a hypothesis and suggestions for therapeutic interventions based on it.
    van Steensel MA
    Med Hypotheses; 2004; 63(1):31-4. PubMed ID: 15193343
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Systemic reaction induced my minocycline treatment: a report of four patients and a review of the literature].
    Piette AM; Ramanoelina J; Gepner P; Larroche C; Blétry O
    Rev Med Interne; 1999 Oct; 20(10):869-74. PubMed ID: 10573723
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Safety of long-term high-dose minocycline in the treatment of acne.
    Goulden V; Glass D; Cunliffe WJ
    Br J Dermatol; 1996 Apr; 134(4):693-5. PubMed ID: 8733373
    [TBL] [Abstract][Full Text] [Related]  

  • 80. An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction.
    Lupton JR; Figueroa P; Tamjidi P; Berberian BJ; Sulica VI
    Cutis; 1999 Aug; 64(2):91-6. PubMed ID: 10467499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.